Figure 2

Estimated (weighted) proportion of HAV-seropositive study participants by age (error bars indicate 95% confidence intervals (95% CI), German children and adolescents, aged 3–17 years, n = 13,063). The dashed line depicts the estimated mean of the HAV-seroprevalence (13%). Serum samples of children aged 0–2 years were not requested. (The specific values per age including the respective 95% confidence intervals are provided in the supplement; Supplementary Table S1).